Literature DB >> 28442839

The Place of Calprotectin, Lactoferrin, and High-Mobility Group Box 1 Protein on Diagnosis of Acute Appendicitis with Children.

Sevgi Buyukbese Sarsu1, Ayse Binnur Erbagci2, Hasan Ulusal2, Suleyman Cuneyt Karakus3, Özlem Gümüstekin Bulbul4.   

Abstract

The purpose of this study is to investigate the role of serum calprotectin (CP), lactoferrin (LF), and high-mobility group protein B1 (HMGB-1) levels and fecal CP and LF levels in differential diagnosis of acute uncomplicated appendicitis from other causes of abdominal pain and further from complicated appendicitis. Totally, 120 children were included grouped into 4 as: healthy controls, patients with right lower quadrant pain with other than surgical causes, patients with uncomplicated appendicitis, and patients with complicated appendicitis. Serum CP, LF, HMGB-1, C-reactive protein (CRP) levels, and white blood cell (WBC) count were studied as well as the fecal CP and LF levels. There was a statistically significant difference between control group and both uncomplicated and complicated acute appendicitis groups, regarding all parameters. In diagnosis of complicated acute appendicitis, area under curve (AUC) for fecal LF, serum CP, and serum HMGB-1 were determined as 1.00 and the cutoff level was determined as 25 μg/g feces, 670 ng/mL, and 30 ng/mL, respectively. In differential diagnosis of uncomplicated and complicated AA, the most accurate parameter was fecal LF with an AUC of 0.977. At a 60 μg/g cutoff value for this variable, sensitivity, specificity, and accuracy were 96.7, 93.3, and 95.0 %, respectively. In conclusion, HMGB-1, calprotectin, and lactoferrin constitute novel markers in diagnosis of AA. Moreover, their levels may be helpful for the clinicians to judge about the severity of the condition. Larger studies are warranted to determine the diagnostic potential of HMGB-1, LF, and CP in AA diagnosis.

Entities:  

Keywords:  Acute appendicitis; Calprotectin; Children; Diagnosis; High-mobility group box 1 protein; Lactoferrin

Year:  2016        PMID: 28442839      PMCID: PMC5386938          DOI: 10.1007/s12262-015-1441-2

Source DB:  PubMed          Journal:  Indian J Surg        ISSN: 0973-9793            Impact factor:   0.656


  24 in total

1.  Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.

Authors:  Jost Langhorst; Sigrid Elsenbruch; Julia Koelzer; Andreas Rueffer; Andreas Michalsen; Gustav J Dobos
Journal:  Am J Gastroenterol       Date:  2007-10-04       Impact factor: 10.864

2.  Calprotectin: a novel noninvasive marker for intestinal allograft monitoring.

Authors:  Debra Sudan; Luciano Vargas; Yimin Sun; Lisette Bok; Gerard Dijkstra; Alan Langnas
Journal:  Ann Surg       Date:  2007-08       Impact factor: 12.969

3.  Evaluation of the diagnostic accuracy of plasma markers for early diagnosis in patients suspected for acute appendicitis.

Authors:  Dirk H S M Schellekens; Karel W E Hulsewé; Bernadette A C van Acker; Annemarie A van Bijnen; Tom M H de Jaegere; Suprapto H Sastrowijoto; Wim A Buurman; Joep P M Derikx
Journal:  Acad Emerg Med       Date:  2013-07       Impact factor: 3.451

4.  A pilot study on potential new plasma markers for diagnosis of acute appendicitis.

Authors:  Geertje Thuijls; Joep P M Derikx; Fred J Prakken; Bregje Huisman; Annemarie A van Bijnen Ing; Ernest L W E van Heurn; Wim A Buurman; Erik Heineman
Journal:  Am J Emerg Med       Date:  2010-03-25       Impact factor: 2.469

5.  Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease.

Authors:  Jeremy A Tibble; Gudmundur Sigthorsson; Russell Foster; Ian Forgacs; Ingvar Bjarnason
Journal:  Gastroenterology       Date:  2002-08       Impact factor: 22.682

Review 6.  Meta-analysis of the clinical and laboratory diagnosis of appendicitis.

Authors:  R E B Andersson
Journal:  Br J Surg       Date:  2004-01       Impact factor: 6.939

Review 7.  Laboratory markers in IBD: useful, magic, or unnecessary toys?

Authors:  S Vermeire; G Van Assche; P Rutgeerts
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

8.  [Diagnostic value of high mobility group box 1 for acute appendicitis in children].

Authors:  Jian-Fen Hu; Jiang-Yan Wu; Lin Zhang; Long-Gui Yang; Cai-Xia Long
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2014-09

9.  Unraveling the role of high mobility group box protein 1 in severe trauma.

Authors:  Edward Abraham
Journal:  Crit Care       Date:  2009-11-12       Impact factor: 9.097

10.  Evaluation of high mobility group box 1 protein as a presurgical diagnostic marker reflecting the severity of acute appendicitis.

Authors:  Chuanxin Wu; Hang Sun; Hongliang Wang; Junmeng Chi; Qi Liu; Hui Guo; Jianping Gong
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2012-09-04       Impact factor: 2.953

View more
  3 in total

Review 1.  Diagnostic performance of calprotectin and APPY-1 test in pediatric acute appendicitis: a systematic review and a meta-analysis.

Authors:  Javier Arredondo Montero; Carlos Bardají Pascual; Giuseppa Antona; Mónica Bronte Anaut; Natalia López-Andrés; Nerea Martín-Calvo
Journal:  Eur J Trauma Emerg Surg       Date:  2022-05-28       Impact factor: 3.693

2.  Serum Procalcitonin and Lactoferrin in Detection of Acute Appendicitis; a Diagnostic Accuracy Study.

Authors:  Mohammad-Reza Motie; Anvar Soleimani; Arash Soltani; Seyed Isaac Hashemy
Journal:  Emerg (Tehran)       Date:  2018-08-25

3.  sB7H3 in Children with Acute Appendicitis: Its Diagnostic Value and Association with Histological Findings.

Authors:  Xiaochen Du; Yan Chen; Jie Zhu; Zhenjiang Bai; Jun Hua; Ying Li; Haitao Lv; Guangbo Zhang
Journal:  J Immunol Res       Date:  2020-09-01       Impact factor: 4.818

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.